BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34141777)

  • 1. Why
    Huang YJ; Cao ZF; Wang J; Yang J; Wei YJ; Tang YC; Cheng YX; Zhou J; Zhang ZX
    World J Clin Cases; 2021 Jun; 9(17):4143-4158. PubMed ID: 34141777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
    Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
    Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of
    Wang Z; Hou H; Zhang H; Duan X; Li L; Meng L
    Am J Transl Res; 2022; 14(2):849-862. PubMed ID: 35273689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
    Zhang L; Han X; Shi Y
    JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring
    Wang Q; Yang Y; Yang M; Li X; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10827-10843. PubMed ID: 32491995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment.
    Hu J; Sun J
    Oncoimmunology; 2018; 7(10):e1487914. PubMed ID: 30288353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
    Zhao H; Zhang L
    Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of
    Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
    Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
    Wang H; Yan C; Ye H
    Exp Ther Med; 2020 Aug; 20(2):1725-1733. PubMed ID: 32765681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
    Zhao DY; Sun XZ; Yao SK
    World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer.
    Huang L; Zheng S; Fu J; Zhang M; Ge X; Mu N
    Dis Markers; 2022; 2022():6734105. PubMed ID: 36051359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
    Wang X; Duanmu J; Fu X; Li T; Jiang Q
    J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Analysis Regarding the Association Between the
    Li S; Zhao W; Sun M
    Front Genet; 2020; 11():620. PubMed ID: 32612640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.
    Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
    BMC Cancer; 2022 Oct; 22(1):1046. PubMed ID: 36199046
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kanwal M; Ding XJ; Song X; Zhou GB; Cao Y
    Oncotarget; 2018 Feb; 9(15):12226-12239. PubMed ID: 29552305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.